Enhance Health, a precision health platform company delivering at-home monitoring, AI analytics, and care workflows for chronic liver and kidney disease as well as urea cycle disorders, announced today the appointment of Alex Cameron to its Strategic Advisory Board.
Cameron is a globally experienced life sciences executive with a distinguished track record of launching innovative products, building high-performing teams, and leading organizations through significant growth and transformation. His extensive background in diagnostics and laboratory informatics will be instrumental as Enhance Health continues to scale its proactive management platform for chronic diseases.
"We are thrilled to welcome Alex to our advisory board," said Enhance Health CEO Matt Leming. "His deep expertise in overseeing global portfolios and his passion for advancing technologies that improve patient outcomes align perfectly with our mission to turn episodic, reactive care into continuous, proactive management."
Cameron currently serves as Global Vice President and Head of Atellica Solutions at Siemens Healthineers. In this role, he oversees a comprehensive global portfolio that includes analytical instruments, laboratory automation, and informatics. His career also includes senior leadership positions at Becton Dickinson and Zimmer Biomet. Notably, Cameron was a founding member of a diagnostics company that achieved a successful exit to a Fortune 500 company, providing him with unique insights into the startup-to-scale-up lifecycle.
Cameron holds an MBA from The Wharton School, an MS in Bioinformatics from Johns Hopkins University, and a BS in Biology from Dickinson College.
About Enhance Health
Enhance Health is a precision health platform company delivering at-home monitoring and care workflows for chronic liver and kidney disease, as well as urea cycle disorders. By integrating proprietary diagnostics and AI analytics with continuous monitoring, Enhance Health aims to improve patient outcomes and reduce the burden on traditional healthcare systems through proactive, data-driven care. To learn more, visit enhancehealthinc.com
About VIC Tech
Enhance Health is part of the portfolio of VIC Tech, a venture studio focused on creating companies from innovative academic research. Enhance's Breeze is the third device from a VIC Tech portfolio company to receive Breakthrough Device Designation from the FDA, highlighting VIC’s consistent track record of advancing impactful health technologies toward clinical and commercial success.